Elevated Energy Production in Chronic Fatigue Syndrome Patients.
Lawson, Nick, Hsieh, Chung-Han, March, Dana et al. · Journal of nature and science · 2016 · DOI
Quick Summary
This study examined how cells in ME/CFS patients produce energy. Surprisingly, researchers found that patients' blood cells actually produced MORE energy (ATP) than healthy controls, but much of this energy came from sources other than mitochondria (the cell's power plants). The study suggests that ME/CFS fatigue may not be caused by a lack of energy, but rather by an abnormal way the body is producing energy.
Why It Matters
This finding challenges the prevailing assumption that ME/CFS is primarily caused by mitochondrial energy deficiency. Understanding that fatigue may instead involve dysregulated energy production pathways could redirect research toward novel therapeutic targets and help explain why standard energy-boosting approaches have limited efficacy in some patients.
Observed Findings
ATP levels were higher in CFS patients compared to paired controls
Mitochondrial cristae were more condensed in patient cells
Mitochondrial membrane potential remained intact in patient cells
Electron transport chain enzyme activity was normal in patient samples
A substantial portion of elevated ATP originated from non-mitochondrial sources
Inferred Conclusions
ME/CFS fatigue is unlikely caused by severe mitochondrial dysfunction or ATP deficiency
Fatigue in this cohort may be linked to pathological overproduction of ATP via non-mitochondrial pathways (such as anaerobic glycolysis)
Mitochondrial structure and basic function are preserved despite elevated cellular energy production
Remaining Questions
Does increased non-mitochondrial ATP production occur in other tissue types (muscle, brain, immune cells) relevant to ME/CFS pathology?
What molecular mechanisms drive the shift toward non-mitochondrial energy production, and are they the primary drivers of fatigue symptoms?
Does this energy production pattern change over the disease course, or differ among ME/CFS patient subgroups?
What This Study Does Not Prove
This study does not prove that abnormal ATP production causes ME/CFS symptoms—only that an association exists in this patient cohort. The findings are limited to blood cells and may not apply to brain, muscle, or other tissues critical to fatigue pathology. Additionally, it does not establish whether elevated non-mitochondrial ATP production is a cause, consequence, or compensatory response to underlying disease.
Tags
Symptom:Fatigue
Biomarker:MetabolomicsBlood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only